Furthermore, the well-known alcoholic and nonalcoholic fatty liver disease-associated variant in PNPLA3 rs7384099,19,20 has recently been shown to affect the development of HCC in European individuals with CHC9,10,17. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.